These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Impact of ultrafiltration on blood use for atrial septal defect closure in infants and children. Gurbuz AT; Novick WM; Pierce CA; Watson DC Ann Thorac Surg; 1998 Apr; 65(4):1105-8; discussion 1108-9. PubMed ID: 9564936 [TBL] [Abstract][Full Text] [Related]
8. Use of the modified technique of ultrafiltration in pediatric open-heart surgery: a prospective study. Ad N; Snir E; Katz J; Birk E; Vidne BA Isr J Med Sci; 1996 Dec; 32(12):1326-31. PubMed ID: 9007183 [TBL] [Abstract][Full Text] [Related]
9. Modified ultrafiltration in surgical correction of congenital heart disease with cardiopulmonary bypass. Maluf MA Perfusion; 2003 Mar; 18 Suppl 1():61-8. PubMed ID: 12708767 [TBL] [Abstract][Full Text] [Related]
12. Hemofiltration during cardiopulmonary bypass: quality assessment of hemoconcentrated blood. Walpoth BH; Amport T; Schmid R; Kipfer B; Lanz M; Spaeth P; Kurt G; Althaus U Thorac Cardiovasc Surg; 1994 Jun; 42(3):162-9. PubMed ID: 7940487 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcome and blood transfusion after infant cardiac surgery with a routine use of conventional ultrafiltration. Golab HD; Kissler J; de Jong PL; van de Woestijne PC; Takkenberg JJ; Bogers AJ Perfusion; 2015 May; 30(4):323-31. PubMed ID: 25122118 [TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial of pericardial blood processing with a cell-saving device on neurologic markers in elderly patients undergoing coronary artery bypass graft surgery. Carrier M; Denault A; Lavoie J; Perrault LP Ann Thorac Surg; 2006 Jul; 82(1):51-5. PubMed ID: 16798186 [TBL] [Abstract][Full Text] [Related]
15. A new practical technique to reduce allogeneic blood exposure and hospital costs while preserving clotting factors after cardiopulmonary bypass: the Hemobag. Samolyk KA; Beckmann SR; Bissinger RC Perfusion; 2005 Oct; 20(6):343-9. PubMed ID: 16363320 [TBL] [Abstract][Full Text] [Related]
16. Coronary bypass surgery performed off pump does not result in lower in-hospital morbidity than coronary artery bypass grafting performed on pump. Légaré JF; Buth KJ; King S; Wood J; Sullivan JA; Hancock Friesen C; Lee J; Stewart K; Hirsch GM Circulation; 2004 Feb; 109(7):887-92. PubMed ID: 14757693 [TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of mini-cardiopulmonary bypass on hemostasis in coronary artery bypass grafting: analysis of inflammatory response and hemodilution. Ohata T; Mitsuno M; Yamamura M; Tanaka H; Kobayashi Y; Ryomoto M; Yoshioka Y; Tsujiya N; Miyamoto Y ASAIO J; 2008; 54(2):207-9. PubMed ID: 18356657 [TBL] [Abstract][Full Text] [Related]
18. The effect of retrograde autologous priming on intraoperative blood product transfusion in coronary artery bypass grafting. Nanjappa A; Gill J; Sadat U; Colah S; Abu-Omar Y; Nair S Perfusion; 2013 Nov; 28(6):530-5. PubMed ID: 23744846 [TBL] [Abstract][Full Text] [Related]
19. Lowest safe hematocrit level on cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. DiMarco A; Vélez H; SoItero E; Magraner M; Bredy R Bol Asoc Med P R; 2011; 103(2):25-9. PubMed ID: 22111467 [TBL] [Abstract][Full Text] [Related]
20. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass. Dial S; Delabays E; Albert M; Gonzalez A; Camarda J; Law A; Menzies D J Thorac Cardiovasc Surg; 2005 Sep; 130(3):654-61. PubMed ID: 16153909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]